LV12658B - Dry Active Substance Powder Injection Pancake Powders - Google Patents

Dry Active Substance Powder Injection Pancake Powders

Info

Publication number: LV12658B
Authority: LV; Latvia
Prior art keywords: pancake; powders; active substance; powder injection; substance powder
Prior art date: 1998-09-14

Application number

LV010041A

Other languages

Latvian (lv)

Other versions

LV12658A (en

Inventor

Andrew Clark

Mei-Chang Kuo

Cecily Lalor

Barry John Aldous

Original Assignee

Inhale Therapeutic Syst

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1998-09-14

Filing date

2001-03-14

Publication date

2001-09-20

2001-03-14 Application filed by Inhale Therapeutic Syst filed Critical Inhale Therapeutic Syst

2001-05-20 Publication of LV12658A publication Critical patent/LV12658A/en

2001-09-20 Publication of LV12658B publication Critical patent/LV12658B/en

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
- A61K47/36—Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/007—Pulmonary tract; Aromatherapy
- A61K9/0073—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy
- A61K9/0075—Sprays or powders for inhalation; Aerolised or nebulised preparations generated by other means than thermal energy for inhalation via a dry powder inhaler [DPI], e.g. comprising micronized drug mixed with lactose carrier particles
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/08—Bronchodilators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
General Health & Medical Sciences (AREA)
Pharmacology & Pharmacy (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Life Sciences & Earth Sciences (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Pulmonology (AREA)
Epidemiology (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Otolaryngology (AREA)
Inorganic Chemistry (AREA)
Medicinal Preparation (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Solid-Sorbent Or Filter-Aiding Compositions (AREA)

LV010041A 1998-09-14 2001-03-14 Dry Active Substance Powder Injection Pancake Powders LV12658B (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US10016398P	1998-09-14	1998-09-14
PCT/US1999/021109 WO2000015262A1 (en)	1998-09-14	1999-09-13	Dry powder active agent pulmonary delivery

Publications (2)

Publication Number	Publication Date
LV12658A LV12658A (en)	2001-05-20
LV12658B true LV12658B (en)	2001-09-20

Family

ID=22278404

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
LV010041A LV12658B (en)	1998-09-14	2001-03-14	Dry Active Substance Powder Injection Pancake Powders

Country Status (44)

Country	Link
EP (1)	EP1117442A1 (en)
JP (1)	JP2002524535A (en)
KR (1)	KR20010075063A (en)
CN (1)	CN1317977A (en)
AP (1)	AP1374A (en)
AR (1)	AR022090A1 (en)
AU (1)	AU753014B2 (en)
BG (1)	BG105430A (en)
BR (1)	BR9913722A (en)
CA (1)	CA2343920A1 (en)
CO (1)	CO5130023A1 (en)
CZ (1)	CZ2001829A3 (en)
DZ (1)	DZ2892A1 (en)
EA (1)	EA003476B1 (en)
EE (1)	EE200100151A (en)
GE (1)	GEP20043257B (en)
GT (1)	GT199900156A (en)
HK (1)	HK1042231A1 (en)
HN (1)	HN1999000159A (en)
HR (1)	HRP20010189A2 (en)
HU (1)	HUP0103837A3 (en)
ID (1)	ID28845A (en)
IL (2)	IL141562A0 (en)
IS (1)	IS5878A (en)
LT (1)	LT4897B (en)
LV (1)	LV12658B (en)
MA (1)	MA25590A1 (en)
MY (1)	MY129282A (en)
NO (1)	NO20011251L (en)
NZ (1)	NZ510168A (en)
OA (1)	OA11781A (en)
PA (1)	PA8481901A1 (en)
PE (1)	PE20001061A1 (en)
PL (1)	PL195574B1 (en)
SA (1)	SA99200718B1 (en)
SK (1)	SK3442001A3 (en)
TN (1)	TNSN99173A1 (en)
TR (1)	TR200101182T2 (en)
TW (1)	TWI226248B (en)
UA (1)	UA76085C2 (en)
UY (1)	UY25711A1 (en)
WO (1)	WO2000015262A1 (en)
YU (1)	YU24201A (en)
ZA (1)	ZA200101995B (en)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US6956021B1 (en)	1998-08-25	2005-10-18	Advanced Inhalation Research, Inc.	Stable spray-dried protein formulations
WO2000075281A2 (en)	1999-06-09	2000-12-14	University Technology Corporation	Supercritical fluid-assisted nebulization and bubble drying
US6475468B2 (en) *	2001-02-15	2002-11-05	Aeropharm Technology Incorporated	Modulated release particles for aerosol delivery
CA2446904A1 (en) *	2001-05-24	2003-04-03	Alexza Molecular Delivery Corporation	Delivery of drug esters through an inhalation route
EG24184A (en)	2001-06-15	2008-10-08	Otsuka Pharma Co Ltd	Dry powder inhalation system for transpulmonary
WO2003043585A2 (en)	2001-11-20	2003-05-30	Advanced Inhalation Research, Inc.	Improved particulate compositions for pulmonary delivery
JP2005518453A (en)	2002-02-25	2005-06-23	ディフュージョン・ファーマシューティカルズ・エルエルシー	Bipolar trans carotenoid salts and their use
US7759506B2 (en)	2002-02-25	2010-07-20	Diffusion Pharmaceuticals Llc	Bipolar trans carotenoid salts and their uses
AU2003232081B2 (en) *	2002-07-03	2009-02-05	Brandeis University	Central airway administration for systemic delivery of therapeutics
EP1575563B1 (en) *	2002-12-19	2007-02-14	Pharmacia Corporation	Non-hygroscopic formulation comprising a hydroscopic drug
DE10338403A1 (en) *	2003-08-18	2005-03-17	Boehringer Ingelheim Pharma Gmbh & Co. Kg	Powder formulation containing the CGRP antagonist 1- [N 2 - [3,5-dibromo-N - [[4- (3,4-dihydro-2 (1 H) -oxoquinazolin-3-yl] -1-piperidinyl] carbonyl] -D-tyrosyl] -L-lysyl] -4- (4-pyrindinyl) piperazine, process for its preparation and its use as inhalant
GB0327723D0 (en) *	2003-09-15	2003-12-31	Vectura Ltd	Pharmaceutical compositions
US20070020299A1 (en)	2003-12-31	2007-01-25	Pipkin James D	Inhalant formulation containing sulfoalkyl ether cyclodextrin and corticosteroid
KR101725225B1 (en)	2004-04-23	2017-04-12	사이덱스 파마슈티칼스, 인크.	DPI formulation containing sulfoalkyl ether cyclodextrin
EP1853544A4 (en) *	2005-02-24	2010-06-16	Diffusion Pharmaceuticals Llc	Trans carotenoids, their synthesis, formulation and uses
JPWO2006095788A1 (en) *	2005-03-09	2008-08-14	小野薬品工業株式会社	Particles and formulations containing the particles
HUE035181T2 (en)	2005-10-26	2018-05-02	Cydex Pharmaceuticals Inc	Sulphoalkyl ether cyclodextrin compositions and methods for their preparation
US7629331B2 (en)	2005-10-26	2009-12-08	Cydex Pharmaceuticals, Inc.	Sulfoalkyl ether cyclodextrin compositions and methods of preparation thereof
US20100269819A1 (en) *	2006-08-14	2010-10-28	Sievers Robert E	Human Powered Dry Powder Inhaler and Dry Powder Inhaler Compositions
WO2008050847A1 (en) *	2006-10-25	2008-05-02	Dainippon Sumitomo Pharma Co., Ltd.	Granular preparation prevented from caking
EP1925295A1 (en) *	2006-11-22	2008-05-28	Boehringer Ingelheim Pharma GmbH & Co. KG	Stable powder formulation containing a new antichinolinergic agent
EA200970944A1 (en)	2007-04-13	2010-06-30	Диффьюжн Фармасьютикалз Ллс	APPLICATION OF BIPOLAR TRANSCAROTINOIDS AS A PRELIMINARY TREATMENT IN THE TREATMENT OF PERIPHERAL VESSEL DISEASES
US12370352B2 (en)	2007-06-28	2025-07-29	Cydex Pharmaceuticals, Inc.	Nasal and ophthalmic delivery of aqueous corticosteroid solutions
JP2011502125A (en)	2007-10-31	2011-01-20	ディフュージョン・ファーマシューティカルズ・エルエルシー	A new class of treatments that promote small molecule diffusion
DK2432502T3 (en)	2009-05-20	2018-03-12	Aeras	STABLE, SPRAY DRIED, IMMUNOGENE, VIRUS COMPOSITIONS
CN108464976A (en)	2009-06-22	2018-08-31	扩散药品有限公司	Diffusion promotes compound and its independent or application together with Thrombolytic Drugs
US8974822B2 (en)	2010-06-02	2015-03-10	Diffusion Pharmaceuticals Llc	Oral formulations of bipolar trans carotenoids
ES2911116T3 (en)	2012-05-03	2022-05-17	Janssen Sciences Ireland Unlimited Co	Polyinosinic Polycytidylic Acid (Poly(I:C)) Formulations for the Treatment of Upper Respiratory Tract Infections
WO2014074797A1 (en) *	2012-11-09	2014-05-15	Civitas Therapeutics, Inc.	Ultra low density pulmonary powders
US20180043585A9 (en) *	2013-09-20	2018-02-15	Virginia Commonwealth University	Delivery of particles using hygroscopic excipients
EP3212212B1 (en)	2014-10-31	2020-09-23	Monash University	Powder formulation
KR102489034B1 (en)	2016-03-24	2023-01-13	디퓨젼 파마슈티컬즈 엘엘씨	Use of Bipolar Trans Carotenoids with Chemotherapy and Radiation Therapy to Treat Cancer
US20220378727A1 (en) *	2021-05-14	2022-12-01	The University Of Hong Kong	Dry powder formulations of tamibarotene for pulmonary and intranasal delivery

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3155573A (en) *	1958-05-06	1964-11-03	Benger Lab Ltd	Inhalant composition and method of making same
DE69332240T2 (en) *	1992-06-12	2003-04-10	Teijin Ltd., Osaka	ULTRA FINE POWDER FOR INHALATION AND PRODUCTION
US6524557B1 (en) *	1994-12-22	2003-02-25	Astrazeneca Ab	Aerosol formulations of peptides and proteins
US5874064A (en)	1996-05-24	1999-02-23	Massachusetts Institute Of Technology	Aerodynamically light particles for pulmonary drug delivery
ES2236832T3 (en) *	1997-01-16	2005-07-16	Massachusetts Institute Of Technology	PREPARATION OF PARTICLES FOR INHALATION.
US6086376A (en) *	1998-01-30	2000-07-11	Rtp Pharma Inc.	Dry aerosol suspension of phospholipid-stabilized drug microparticles in a hydrofluoroalkane propellant

1999
- 1999-09-09 MA MA25762A patent/MA25590A1/en unknown
- 1999-09-13 CZ CZ2001829A patent/CZ2001829A3/en unknown
- 1999-09-13 UA UA2001031707A patent/UA76085C2/en unknown
- 1999-09-13 HR HR20010189A patent/HRP20010189A2/en not_active Application Discontinuation
- 1999-09-13 TR TR2001/01182T patent/TR200101182T2/en unknown
- 1999-09-13 MY MYPI99003947A patent/MY129282A/en unknown
- 1999-09-13 EE EEP200100151A patent/EE200100151A/en unknown
- 1999-09-13 SK SK344-2001A patent/SK3442001A3/en unknown
- 1999-09-13 AU AU60397/99A patent/AU753014B2/en not_active Ceased
- 1999-09-13 BR BR9913722-4A patent/BR9913722A/en not_active IP Right Cessation
- 1999-09-13 JP JP2000569846A patent/JP2002524535A/en not_active Withdrawn
- 1999-09-13 ZA ZA200101995A patent/ZA200101995B/en unknown
- 1999-09-13 EP EP99969035A patent/EP1117442A1/en not_active Withdrawn
- 1999-09-13 ID IDW20010582A patent/ID28845A/en unknown
- 1999-09-13 HU HU0103837A patent/HUP0103837A3/en unknown
- 1999-09-13 HN HN1999000159A patent/HN1999000159A/en unknown
- 1999-09-13 NZ NZ510168A patent/NZ510168A/en unknown
- 1999-09-13 EA EA200100300A patent/EA003476B1/en active IP Right Revival
- 1999-09-13 PE PE1999000925A patent/PE20001061A1/en not_active Application Discontinuation
- 1999-09-13 HK HK02101738.3A patent/HK1042231A1/en unknown
- 1999-09-13 TW TW088115876A patent/TWI226248B/en not_active IP Right Cessation
- 1999-09-13 YU YU24201A patent/YU24201A/en unknown
- 1999-09-13 KR KR1020017003208A patent/KR20010075063A/en not_active Ceased
- 1999-09-13 PL PL99346768A patent/PL195574B1/en not_active IP Right Cessation
- 1999-09-13 WO PCT/US1999/021109 patent/WO2000015262A1/en not_active Ceased
- 1999-09-13 AR ARP990104587A patent/AR022090A1/en unknown
- 1999-09-13 CN CN99810871A patent/CN1317977A/en active Pending
- 1999-09-13 DZ DZ990192A patent/DZ2892A1/en active
- 1999-09-13 CA CA002343920A patent/CA2343920A1/en not_active Abandoned
- 1999-09-13 GE GEAP19995857A patent/GEP20043257B/en unknown
- 1999-09-13 AP APAP/P/2001/002093A patent/AP1374A/en active
- 1999-09-13 OA OA1200100063A patent/OA11781A/en unknown
- 1999-09-13 IL IL14156299A patent/IL141562A0/en not_active IP Right Cessation
- 1999-09-14 UY UY25711A patent/UY25711A1/en not_active Application Discontinuation
- 1999-09-14 PA PA19998481901A patent/PA8481901A1/en unknown
- 1999-09-14 TN TNTNSN99173A patent/TNSN99173A1/en unknown
- 1999-09-14 GT GT199900156A patent/GT199900156A/en unknown
- 1999-09-14 CO CO99058265A patent/CO5130023A1/en unknown
- 1999-10-31 SA SA99200718A patent/SA99200718B1/en unknown
2001
- 2001-02-21 IL IL141562A patent/IL141562A/en unknown
- 2001-03-05 IS IS5878A patent/IS5878A/en unknown
- 2001-03-13 NO NO20011251A patent/NO20011251L/en not_active Application Discontinuation
- 2001-03-14 LV LV010041A patent/LV12658B/en unknown
- 2001-03-14 LT LT2001021A patent/LT4897B/en not_active IP Right Cessation
- 2001-04-10 BG BG105430A patent/BG105430A/en unknown

Also Published As

Publication number	Publication date
MY129282A (en)	2007-03-30
CZ2001829A3 (en)	2001-09-12
GEP20043257B (en)	2004-06-25
SK3442001A3 (en)	2001-11-06
TWI226248B (en)	2005-01-11
UA76085C2 (en)	2006-07-17
LT2001021A (en)	2001-11-26
TR200101182T2 (en)	2001-09-21
BR9913722A (en)	2001-05-29
KR20010075063A (en)	2001-08-09
PL195574B1 (en)	2007-10-31
IL141562A0 (en)	2002-03-10
NO20011251D0 (en)	2001-03-13
NO20011251L (en)	2001-04-17
AU753014B2 (en)	2002-10-03
ZA200101995B (en)	2002-03-11
SA99200718B1 (en)	2006-11-04
NZ510168A (en)	2003-09-26
PA8481901A1 (en)	2002-04-25
GT199900156A (en)	2001-03-07
AP1374A (en)	2005-02-28
TNSN99173A1 (en)	2005-11-10
LV12658A (en)	2001-05-20
ID28845A (en)	2001-07-05
PL346768A1 (en)	2002-02-25
IL141562A (en)	2007-07-24
JP2002524535A (en)	2002-08-06
HUP0103837A2 (en)	2002-05-29
HRP20010189A2 (en)	2005-04-30
HUP0103837A3 (en)	2002-11-28
EE200100151A (en)	2002-06-17
CN1317977A (en)	2001-10-17
YU24201A (en)	2003-08-29
HN1999000159A (en)	1999-11-11
DZ2892A1 (en)	2003-12-15
EP1117442A1 (en)	2001-07-25
EA200100300A1 (en)	2001-10-22
AP2001002093A0 (en)	2001-03-31
WO2000015262A1 (en)	2000-03-23
IS5878A (en)	2001-03-05
CA2343920A1 (en)	2000-03-23
LT4897B (en)	2002-02-25
EA003476B1 (en)	2003-06-26
OA11781A (en)	2005-07-26
AR022090A1 (en)	2002-09-04
HK1042231A1 (en)	2002-08-09
CO5130023A1 (en)	2002-02-27
BG105430A (en)	2001-12-29
AU6039799A (en)	2000-04-03
MA25590A1 (en)	2002-12-31
PE20001061A1 (en)	2000-10-08
UY25711A1 (en)	1999-11-17

Publication	Publication Date	Title
LV12658B (en)	2001-09-20	Dry Active Substance Powder Injection Pancake Powders
DE60035911D1 (en)	2007-09-20	dry powder inhaler
HUP0001799A3 (en)	2000-10-30	Dry powder inhaler
IS4364A (en)	1996-10-29	Dry powder inhalers
EP0927025A4 (en)	2001-07-25	Liposome encapsulated active agent dry powder composition
EE200400122A (en)	2005-02-15	Powder inhaler
FI954098A7 (en)	1995-09-01	Dry powder inhaler drug carrier
DE69428743D1 (en)	2001-11-29	Dry powder inhaler
FI962272L (en)	1996-05-30	Dry powder inhaler drug carrier
FI951838A7 (en)	1995-04-18	Dry powder inhaler
ATE460955T1 (en)	2010-04-15	DRY POWDER INHALER
NO994519L (en)	1999-11-19	Preparation of powder agglomerates
DE60023254D1 (en)	2006-03-02	Cosmetic compact powder composition
DE69928085D1 (en)	2005-12-08	DOSAGE FORM WITH EXTENDED ACTIVE SUBSTANCE
DE69839356D1 (en)	2008-05-21	Dry powder inhaler for capsules
HUP0104483A3 (en)	2002-04-29	Fungicidal active substance combinations and use thereof
EP1065675A4 (en)	2001-05-16	FERROMAGNETIC POWDER
DE69926719D1 (en)	2005-09-22	NICKEL-METAL POWDER
AU2001243611A1 (en)	2001-10-03	Stabilized dry powder formulations
DE69919490D1 (en)	2004-09-23	POWDER WITH FAT-SOLUBLE ACTIVE SUBSTANCE
GB9916316D0 (en)	1999-09-15	Dry powder compositions
ID18341A (en)	1998-04-02	DRY POWDER CHEESE COMPOSITIONS
ID23192A (en)	2000-03-23	PROLIPOSOMA POWDER FOR INHABILITATION IN STABILIZED BY TOKOFEROL
GB9719093D0 (en)	1997-11-12	Improvements to dry powder inhalers
GB0003935D0 (en)	2000-04-12	Formulation for dry powder inhaler